Article Details
Retrieved on: 2017-12-10 20:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>... published positive results from a first-in-human proof-of-concept trial in rheumatoid arthritis in Proceedings of the National Academy of Sciences (PNAS) and presented positive results at the American College of Rheumatology meeting. Current investors in the company include <b>Morgenthaler Ventures</b>, ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here